FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
ANI Pharmaceuticals, Inc. Stock AnalysisComprehensive stock analysis for ANI Pharmaceuticals, Inc. (ANIP) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisANIP
ANIP
ANI Pharmaceuticals, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ANIP
Home🔹Stocks🔹ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

ANIP•NASDAQ

ANI Pharmaceuticals, Inc.

ANIP•NASDAQ
Market cap
$1.84B
Sentiment

Your view on ANIP

Mkt Cap
$1.84B
Sentiment
Your view
ANIP
ANI Pharmaceuticals, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ANIP
Company Overview

Overview

What the company does, where it operates, and who runs it.

About ANI Pharmaceuticals, Inc.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Nikhil Lalwani
Headquarters
210 Main Street West, Baudette, MN, US
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Nikhil Lalwani
Headquarters
210 Main Street West, Baudette, MN, US
Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News